-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Adult Clinical Malignant Hematology

Program: Trainee Activities and Services
Session: Career Development Lunch
Saturday, December 9, 2023, 11:15 AM-12:15 PM

Marlise R. Luskin, MD

Dana-Farber Cancer Institute, Boston, MA

Disclosures: Luskin: Novartis: Honoraria; Novartis: Research Funding; Pfizer: Honoraria; Jazz: Honoraria; AbbVie: Research Funding.